前沿论文｜CELL INTELLIGENCE

SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel Targets.

PubMed 2026/04/28 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1（JCR 2025）

52.2分

★★★☆☆

站内排序·非疗效

CD38 as a pan-hematologic target for chimeric antigen receptor T cells.

PubMed 2023/08/22 发表Blood AdvQ1 · IF 7.7（JCR 2025）

47.2分

★★★☆☆

站内排序·非疗效

Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma.

PubMed 2023/01/30 发表Chem SciQ1 · IF 8.1（JCR 2025）

47.2分

★★★☆☆

站内排序·非疗效

Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.

PubMed 2023/02/02 发表Best Pract Res Clin HaematolQ2 · IF 3.4（JCR 2025）

31.6分

★☆☆☆☆

站内排序·非疗效

Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigens.

PubMed 2025/06/30 发表Blood Neoplasia

22.0分

★☆☆☆☆

站内排序·非疗效

前沿论文 5